American Scientific Resources, Incorporated
American Scientific Resources, Incorporated ASFX Peers
See (ASFX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ASFX | $0.00 | -0.00% | 17.5K | N/A | -$0.70 | N/A |
| SRTOY | $21.85 | -1.65% | 212.5B | 87.38 | $0.25 | +0.35% |
| ESLOF | $282.81 | -2.65% | 133.6B | 47.60 | $6.07 | +1.54% |
| ESLOY | $142.29 | +0.56% | 131B | 47.05 | $3.02 | +1.58% |
| MECNY | $88.63 | +0.00% | 107.8B | N/A | N/A | N/A |
| SOAGY | $44.86 | -6.36% | 73.9B | 147.41 | $0.32 | +0.18% |
| HOCPY | $122.35 | -0.72% | 42.8B | 30.97 | $4.02 | +0.41% |
| HOCPF | $127.11 | +0.70% | 42.1B | 31.03 | $3.99 | +1.22% |
| RSMDF | $23.42 | -7.10% | 29.3B | 26.31 | $0.89 | +0.81% |
| TRUMY | $15.97 | -1.11% | 24.1B | 29.73 | $0.55 | +0.64% |
Stock Comparison
ASFX vs SRTOY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SRTOY has a market cap of 212.5B. Regarding current trading prices, ASFX is priced at $0.00, while SRTOY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SRTOY's P/E ratio is 87.38. In terms of profitability, ASFX's ROE is +0.00%, compared to SRTOY's ROE of +0.05%. Regarding short-term risk, ASFX and SRTOY have similar daily volatility (0.00).
ASFX vs ESLOF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, ESLOF has a market cap of 133.6B. Regarding current trading prices, ASFX is priced at $0.00, while ESLOF trades at $282.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas ESLOF's P/E ratio is 47.60. In terms of profitability, ASFX's ROE is +0.00%, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, ASFX is less volatile compared to ESLOF. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs ESLOY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, ESLOY has a market cap of 131B. Regarding current trading prices, ASFX is priced at $0.00, while ESLOY trades at $142.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas ESLOY's P/E ratio is 47.05. In terms of profitability, ASFX's ROE is +0.00%, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, ASFX is less volatile compared to ESLOY. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs MECNY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, MECNY has a market cap of 107.8B. Regarding current trading prices, ASFX is priced at $0.00, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas MECNY's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to MECNY's ROE of +0.07%. Regarding short-term risk, ASFX and MECNY have similar daily volatility (0.00).
ASFX vs SOAGY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SOAGY has a market cap of 73.9B. Regarding current trading prices, ASFX is priced at $0.00, while SOAGY trades at $44.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SOAGY's P/E ratio is 147.41. In terms of profitability, ASFX's ROE is +0.00%, compared to SOAGY's ROE of +0.05%. Regarding short-term risk, ASFX is less volatile compared to SOAGY. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs HOCPY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, HOCPY has a market cap of 42.8B. Regarding current trading prices, ASFX is priced at $0.00, while HOCPY trades at $122.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas HOCPY's P/E ratio is 30.97. In terms of profitability, ASFX's ROE is +0.00%, compared to HOCPY's ROE of +0.20%. Regarding short-term risk, ASFX is less volatile compared to HOCPY. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs HOCPF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, HOCPF has a market cap of 42.1B. Regarding current trading prices, ASFX is priced at $0.00, while HOCPF trades at $127.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas HOCPF's P/E ratio is 31.03. In terms of profitability, ASFX's ROE is +0.00%, compared to HOCPF's ROE of +0.21%. Regarding short-term risk, ASFX and HOCPF have similar daily volatility (0.00).
ASFX vs RSMDF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, RSMDF has a market cap of 29.3B. Regarding current trading prices, ASFX is priced at $0.00, while RSMDF trades at $23.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas RSMDF's P/E ratio is 26.31. In terms of profitability, ASFX's ROE is +0.00%, compared to RSMDF's ROE of +0.25%. Regarding short-term risk, ASFX and RSMDF have similar daily volatility (0.00).
ASFX vs TRUMY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, TRUMY has a market cap of 24.1B. Regarding current trading prices, ASFX is priced at $0.00, while TRUMY trades at $15.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas TRUMY's P/E ratio is 29.73. In terms of profitability, ASFX's ROE is +0.00%, compared to TRUMY's ROE of +0.09%. Regarding short-term risk, ASFX is less volatile compared to TRUMY. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs TRUMF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, TRUMF has a market cap of 23.7B. Regarding current trading prices, ASFX is priced at $0.00, while TRUMF trades at $18.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas TRUMF's P/E ratio is 29.79. In terms of profitability, ASFX's ROE is +0.00%, compared to TRUMF's ROE of +0.09%. Regarding short-term risk, ASFX is less volatile compared to TRUMF. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs SDMHF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SDMHF has a market cap of 23.4B. Regarding current trading prices, ASFX is priced at $0.00, while SDMHF trades at $210.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SDMHF's P/E ratio is 98.36. In terms of profitability, ASFX's ROE is +0.00%, compared to SDMHF's ROE of +0.05%. Regarding short-term risk, ASFX is less volatile compared to SDMHF. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs CLPBY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, CLPBY has a market cap of 21.5B. Regarding current trading prices, ASFX is priced at $0.00, while CLPBY trades at $9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas CLPBY's P/E ratio is 29.41. In terms of profitability, ASFX's ROE is +0.00%, compared to CLPBY's ROE of +0.27%. Regarding short-term risk, ASFX is less volatile compared to CLPBY. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs SAUHF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SAUHF has a market cap of 21.2B. Regarding current trading prices, ASFX is priced at $0.00, while SAUHF trades at $129.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SAUHF's P/E ratio is 36.73. In terms of profitability, ASFX's ROE is +0.00%, compared to SAUHF's ROE of +0.14%. Regarding short-term risk, ASFX is less volatile compared to SAUHF. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs CLPBF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, CLPBF has a market cap of 21.2B. Regarding current trading prices, ASFX is priced at $0.00, while CLPBF trades at $95.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas CLPBF's P/E ratio is 29.68. In terms of profitability, ASFX's ROE is +0.00%, compared to CLPBF's ROE of +0.27%. Regarding short-term risk, ASFX and CLPBF have similar daily volatility (0.00).
ASFX vs SAUHY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SAUHY has a market cap of 21B. Regarding current trading prices, ASFX is priced at $0.00, while SAUHY trades at $13.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SAUHY's P/E ratio is 36.58. In terms of profitability, ASFX's ROE is +0.00%, compared to SAUHY's ROE of +0.14%. Regarding short-term risk, ASFX is less volatile compared to SAUHY. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs SARTF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SARTF has a market cap of 15.3B. Regarding current trading prices, ASFX is priced at $0.00, while SARTF trades at $200.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SARTF's P/E ratio is 124.35. In terms of profitability, ASFX's ROE is +0.00%, compared to SARTF's ROE of +0.05%. Regarding short-term risk, ASFX and SARTF have similar daily volatility (0.00).
ASFX vs SSSGY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SSSGY has a market cap of 15.3B. Regarding current trading prices, ASFX is priced at $0.00, while SSSGY trades at $42.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SSSGY's P/E ratio is 131.59. In terms of profitability, ASFX's ROE is +0.00%, compared to SSSGY's ROE of +0.05%. Regarding short-term risk, ASFX and SSSGY have similar daily volatility (0.00).
ASFX vs SUVPF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SUVPF has a market cap of 15B. Regarding current trading prices, ASFX is priced at $0.00, while SUVPF trades at $259.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SUVPF's P/E ratio is 160.88. In terms of profitability, ASFX's ROE is +0.00%, compared to SUVPF's ROE of +0.05%. Regarding short-term risk, ASFX and SUVPF have similar daily volatility (0.00).
ASFX vs FSPKF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, FSPKF has a market cap of 13B. Regarding current trading prices, ASFX is priced at $0.00, while FSPKF trades at $22.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas FSPKF's P/E ratio is 58.16. In terms of profitability, ASFX's ROE is +0.00%, compared to FSPKF's ROE of +0.28%. Regarding short-term risk, ASFX and FSPKF have similar daily volatility (0.00).
ASFX vs OCPNF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, OCPNF has a market cap of 12.9B. Regarding current trading prices, ASFX is priced at $0.00, while OCPNF trades at $11.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas OCPNF's P/E ratio is 15.90. In terms of profitability, ASFX's ROE is +0.00%, compared to OCPNF's ROE of +0.16%. Regarding short-term risk, ASFX and OCPNF have similar daily volatility (0.00).
ASFX vs SSMXY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SSMXY has a market cap of 10.5B. Regarding current trading prices, ASFX is priced at $0.00, while SSMXY trades at $16.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SSMXY's P/E ratio is 28.44. In terms of profitability, ASFX's ROE is +0.00%, compared to SSMXY's ROE of +0.12%. Regarding short-term risk, ASFX is less volatile compared to SSMXY. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs SSMXF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SSMXF has a market cap of 9.9B. Regarding current trading prices, ASFX is priced at $0.00, while SSMXF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SSMXF's P/E ratio is 26.78. In terms of profitability, ASFX's ROE is +0.00%, compared to SSMXF's ROE of +0.12%. Regarding short-term risk, ASFX and SSMXF have similar daily volatility (0.00).
ASFX vs CNVVF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, CNVVF has a market cap of 7.6B. Regarding current trading prices, ASFX is priced at $0.00, while CNVVF trades at $3.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas CNVVF's P/E ratio is 41.11. In terms of profitability, ASFX's ROE is +0.00%, compared to CNVVF's ROE of +0.16%. Regarding short-term risk, ASFX is less volatile compared to CNVVF. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs YPHDF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, YPHDF has a market cap of 7.3B. Regarding current trading prices, ASFX is priced at $0.00, while YPHDF trades at $535.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas YPHDF's P/E ratio is 67.38. In terms of profitability, ASFX's ROE is +0.00%, compared to YPHDF's ROE of +0.13%. Regarding short-term risk, ASFX is less volatile compared to YPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs CNVVY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, CNVVY has a market cap of 6.8B. Regarding current trading prices, ASFX is priced at $0.00, while CNVVY trades at $13.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas CNVVY's P/E ratio is 36.16. In terms of profitability, ASFX's ROE is +0.00%, compared to CNVVY's ROE of +0.16%. Regarding short-term risk, ASFX is less volatile compared to CNVVY. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs FLMNY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, FLMNY has a market cap of 5.6B. Regarding current trading prices, ASFX is priced at $0.00, while FLMNY trades at $13.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas FLMNY's P/E ratio is 29.53. In terms of profitability, ASFX's ROE is +0.00%, compared to FLMNY's ROE of +0.17%. Regarding short-term risk, ASFX and FLMNY have similar daily volatility (0.00).
ASFX vs FLMNF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, FLMNF has a market cap of 5.4B. Regarding current trading prices, ASFX is priced at $0.00, while FLMNF trades at $64.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas FLMNF's P/E ratio is 28.19. In terms of profitability, ASFX's ROE is +0.00%, compared to FLMNF's ROE of +0.17%. Regarding short-term risk, ASFX and FLMNF have similar daily volatility (0.00).
ASFX vs CZMWY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, CZMWY has a market cap of 5.2B. Regarding current trading prices, ASFX is priced at $0.00, while CZMWY trades at $59.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas CZMWY's P/E ratio is 28.64. In terms of profitability, ASFX's ROE is +0.00%, compared to CZMWY's ROE of +0.07%. Regarding short-term risk, ASFX is less volatile compared to CZMWY. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs ADDLF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, ADDLF has a market cap of 4.9B. Regarding current trading prices, ASFX is priced at $0.00, while ADDLF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, ASFX's ROE is +0.00%, compared to ADDLF's ROE of +0.06%. Regarding short-term risk, ASFX and ADDLF have similar daily volatility (0.00).
ASFX vs CZMWF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, CZMWF has a market cap of 4.9B. Regarding current trading prices, ASFX is priced at $0.00, while CZMWF trades at $59.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas CZMWF's P/E ratio is 26.84. In terms of profitability, ASFX's ROE is +0.00%, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, ASFX and CZMWF have similar daily volatility (0.00).
ASFX vs AHICF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, AHICF has a market cap of 4.4B. Regarding current trading prices, ASFX is priced at $0.00, while AHICF trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas AHICF's P/E ratio is 59.89. In terms of profitability, ASFX's ROE is +0.00%, compared to AHICF's ROE of +0.07%. Regarding short-term risk, ASFX and AHICF have similar daily volatility (0.00).
ASFX vs TEVNF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, TEVNF has a market cap of 3.2B. Regarding current trading prices, ASFX is priced at $0.00, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas TEVNF's P/E ratio is -0.21. In terms of profitability, ASFX's ROE is +0.00%, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, ASFX and TEVNF have similar daily volatility (0.00).
ASFX vs ANSLY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, ANSLY has a market cap of 3B. Regarding current trading prices, ASFX is priced at $0.00, while ANSLY trades at $79.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas ANSLY's P/E ratio is 25.72. In terms of profitability, ASFX's ROE is +0.00%, compared to ANSLY's ROE of +0.04%. Regarding short-term risk, ASFX and ANSLY have similar daily volatility (0.00).
ASFX vs SHWGF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SHWGF has a market cap of 3B. Regarding current trading prices, ASFX is priced at $0.00, while SHWGF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SHWGF's P/E ratio is 11.02. In terms of profitability, ASFX's ROE is +0.00%, compared to SHWGF's ROE of +0.09%. Regarding short-term risk, ASFX and SHWGF have similar daily volatility (0.00).
ASFX vs ANSLF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, ANSLF has a market cap of 2.6B. Regarding current trading prices, ASFX is priced at $0.00, while ANSLF trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas ANSLF's P/E ratio is 22.22. In terms of profitability, ASFX's ROE is +0.00%, compared to ANSLF's ROE of +0.06%. Regarding short-term risk, ASFX and ANSLF have similar daily volatility (0.00).
ASFX vs TCGGY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, TCGGY has a market cap of 2.6B. Regarding current trading prices, ASFX is priced at $0.00, while TCGGY trades at $36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas TCGGY's P/E ratio is 30.55. In terms of profitability, ASFX's ROE is +0.00%, compared to TCGGY's ROE of +0.07%. Regarding short-term risk, ASFX and TCGGY have similar daily volatility (0.00).
ASFX vs TCHBF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, TCHBF has a market cap of 2.5B. Regarding current trading prices, ASFX is priced at $0.00, while TCHBF trades at $211.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas TCHBF's P/E ratio is 30.35. In terms of profitability, ASFX's ROE is +0.00%, compared to TCHBF's ROE of +0.07%. Regarding short-term risk, ASFX and TCHBF have similar daily volatility (0.00).
ASFX vs BOEUF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, BOEUF has a market cap of 2.1B. Regarding current trading prices, ASFX is priced at $0.00, while BOEUF trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas BOEUF's P/E ratio is 139.13. In terms of profitability, ASFX's ROE is +0.00%, compared to BOEUF's ROE of +0.18%. Regarding short-term risk, ASFX and BOEUF have similar daily volatility (0.00).
ASFX vs GRRMF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, GRRMF has a market cap of 2B. Regarding current trading prices, ASFX is priced at $0.00, while GRRMF trades at $56.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas GRRMF's P/E ratio is 21.42. In terms of profitability, ASFX's ROE is +0.00%, compared to GRRMF's ROE of +0.05%. Regarding short-term risk, ASFX and GRRMF have similar daily volatility (0.00).
ASFX vs EKTAY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, EKTAY has a market cap of 1.9B. Regarding current trading prices, ASFX is priced at $0.00, while EKTAY trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas EKTAY's P/E ratio is 70.29. In terms of profitability, ASFX's ROE is +0.00%, compared to EKTAY's ROE of +0.02%. Regarding short-term risk, ASFX is less volatile compared to EKTAY. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs EKTAF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, EKTAF has a market cap of 1.9B. Regarding current trading prices, ASFX is priced at $0.00, while EKTAF trades at $5.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas EKTAF's P/E ratio is 73.71. In terms of profitability, ASFX's ROE is +0.00%, compared to EKTAF's ROE of +0.02%. Regarding short-term risk, ASFX and EKTAF have similar daily volatility (0.00).
ASFX vs NPRRF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, NPRRF has a market cap of 1.5B. Regarding current trading prices, ASFX is priced at $0.00, while NPRRF trades at $8.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas NPRRF's P/E ratio is 43.32. In terms of profitability, ASFX's ROE is +0.00%, compared to NPRRF's ROE of N/A. Regarding short-term risk, ASFX and NPRRF have similar daily volatility (0.00).
ASFX vs TDVXF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, TDVXF has a market cap of 1.3B. Regarding current trading prices, ASFX is priced at $0.00, while TDVXF trades at $12.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas TDVXF's P/E ratio is 82.87. In terms of profitability, ASFX's ROE is +0.00%, compared to TDVXF's ROE of +0.39%. Regarding short-term risk, ASFX and TDVXF have similar daily volatility (0.00).
ASFX vs TGLVY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, TGLVY has a market cap of 1.2B. Regarding current trading prices, ASFX is priced at $0.00, while TGLVY trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas TGLVY's P/E ratio is 60.00. In terms of profitability, ASFX's ROE is +0.00%, compared to TGLVY's ROE of +0.02%. Regarding short-term risk, ASFX and TGLVY have similar daily volatility (0.00).
ASFX vs BITGF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, BITGF has a market cap of 1.2B. Regarding current trading prices, ASFX is priced at $0.00, while BITGF trades at $15.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas BITGF's P/E ratio is 45.06. In terms of profitability, ASFX's ROE is +0.00%, compared to BITGF's ROE of +0.06%. Regarding short-term risk, ASFX and BITGF have similar daily volatility (0.00).
ASFX vs PBHDF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, PBHDF has a market cap of 1.1B. Regarding current trading prices, ASFX is priced at $0.00, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, ASFX's ROE is +0.00%, compared to PBHDF's ROE of +0.07%. Regarding short-term risk, ASFX and PBHDF have similar daily volatility (0.00).
ASFX vs SHWGY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SHWGY has a market cap of 983.6M. Regarding current trading prices, ASFX is priced at $0.00, while SHWGY trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SHWGY's P/E ratio is 13.92. In terms of profitability, ASFX's ROE is +0.00%, compared to SHWGY's ROE of +0.09%. Regarding short-term risk, ASFX and SHWGY have similar daily volatility (0.00).
ASFX vs KSRBF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, KSRBF has a market cap of 866.4M. Regarding current trading prices, ASFX is priced at $0.00, while KSRBF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas KSRBF's P/E ratio is 4.87. In terms of profitability, ASFX's ROE is +0.00%, compared to KSRBF's ROE of +0.03%. Regarding short-term risk, ASFX and KSRBF have similar daily volatility (0.00).
ASFX vs NNCSF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, NNCSF has a market cap of 773.5M. Regarding current trading prices, ASFX is priced at $0.00, while NNCSF trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas NNCSF's P/E ratio is 63.69. In terms of profitability, ASFX's ROE is +0.00%, compared to NNCSF's ROE of +0.07%. Regarding short-term risk, ASFX and NNCSF have similar daily volatility (0.00).
ASFX vs SAFLF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SAFLF has a market cap of 544.4M. Regarding current trading prices, ASFX is priced at $0.00, while SAFLF trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SAFLF's P/E ratio is 22.50. In terms of profitability, ASFX's ROE is +0.00%, compared to SAFLF's ROE of +0.05%. Regarding short-term risk, ASFX and SAFLF have similar daily volatility (0.00).
ASFX vs JNDOF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, JNDOF has a market cap of 531M. Regarding current trading prices, ASFX is priced at $0.00, while JNDOF trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, ASFX's ROE is +0.00%, compared to JNDOF's ROE of +0.20%. Regarding short-term risk, ASFX and JNDOF have similar daily volatility (0.00).
ASFX vs HGYMF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, HGYMF has a market cap of 510.1M. Regarding current trading prices, ASFX is priced at $0.00, while HGYMF trades at $24.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas HGYMF's P/E ratio is 32.86. In terms of profitability, ASFX's ROE is +0.00%, compared to HGYMF's ROE of +0.02%. Regarding short-term risk, ASFX and HGYMF have similar daily volatility (0.00).
ASFX vs SAFLY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SAFLY has a market cap of 461.7M. Regarding current trading prices, ASFX is priced at $0.00, while SAFLY trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SAFLY's P/E ratio is 229.00. In terms of profitability, ASFX's ROE is +0.00%, compared to SAFLY's ROE of +0.05%. Regarding short-term risk, ASFX and SAFLY have similar daily volatility (0.00).
ASFX vs SPMXF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SPMXF has a market cap of 458.6M. Regarding current trading prices, ASFX is priced at $0.00, while SPMXF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SPMXF's P/E ratio is -15.00. In terms of profitability, ASFX's ROE is +0.00%, compared to SPMXF's ROE of -0.05%. Regarding short-term risk, ASFX and SPMXF have similar daily volatility (0.00).
ASFX vs CLHLF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, CLHLF has a market cap of 455.6M. Regarding current trading prices, ASFX is priced at $0.00, while CLHLF trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas CLHLF's P/E ratio is 34.82. In terms of profitability, ASFX's ROE is +0.00%, compared to CLHLF's ROE of +0.12%. Regarding short-term risk, ASFX and CLHLF have similar daily volatility (0.00).
ASFX vs GUERF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, ASFX is priced at $0.00, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas GUERF's P/E ratio is 8.19. In terms of profitability, ASFX's ROE is +0.00%, compared to GUERF's ROE of N/A. Regarding short-term risk, ASFX and GUERF have similar daily volatility (0.00).
ASFX vs TSNLF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, TSNLF has a market cap of 252.4M. Regarding current trading prices, ASFX is priced at $0.00, while TSNLF trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas TSNLF's P/E ratio is 33.06. In terms of profitability, ASFX's ROE is +0.00%, compared to TSNLF's ROE of +0.21%. Regarding short-term risk, ASFX and TSNLF have similar daily volatility (0.00).
ASFX vs OPSSF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, OPSSF has a market cap of 247.4M. Regarding current trading prices, ASFX is priced at $0.00, while OPSSF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, ASFX's ROE is +0.00%, compared to OPSSF's ROE of -0.36%. Regarding short-term risk, ASFX is less volatile compared to OPSSF. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs MCDA Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, MCDA has a market cap of 212M. Regarding current trading prices, ASFX is priced at $0.00, while MCDA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas MCDA's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to MCDA's ROE of N/A. Regarding short-term risk, ASFX and MCDA have similar daily volatility (0.00).
ASFX vs EEOIF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, EEOIF has a market cap of 63.4M. Regarding current trading prices, ASFX is priced at $0.00, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, ASFX's ROE is +0.00%, compared to EEOIF's ROE of N/A. Regarding short-term risk, ASFX and EEOIF have similar daily volatility (0.00).
ASFX vs UEEC Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, UEEC has a market cap of 28.3M. Regarding current trading prices, ASFX is priced at $0.00, while UEEC trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas UEEC's P/E ratio is -11.00. In terms of profitability, ASFX's ROE is +0.00%, compared to UEEC's ROE of +1.31%. Regarding short-term risk, ASFX is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs YBGJ Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, YBGJ has a market cap of 16.8M. Regarding current trading prices, ASFX is priced at $0.00, while YBGJ trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas YBGJ's P/E ratio is -6.99. In terms of profitability, ASFX's ROE is +0.00%, compared to YBGJ's ROE of +3.46%. Regarding short-term risk, ASFX is less volatile compared to YBGJ. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs GVDI Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, GVDI has a market cap of 15.8M. Regarding current trading prices, ASFX is priced at $0.00, while GVDI trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas GVDI's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to GVDI's ROE of +0.00%. Regarding short-term risk, ASFX is less volatile compared to GVDI. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs OTCFF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, OTCFF has a market cap of 12.4M. Regarding current trading prices, ASFX is priced at $0.00, while OTCFF trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas OTCFF's P/E ratio is -14.32. In terms of profitability, ASFX's ROE is +0.00%, compared to OTCFF's ROE of -7.85%. Regarding short-term risk, ASFX and OTCFF have similar daily volatility (0.00).
ASFX vs OJSY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, OJSY has a market cap of 9.1M. Regarding current trading prices, ASFX is priced at $0.00, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas OJSY's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to OJSY's ROE of N/A. Regarding short-term risk, ASFX and OJSY have similar daily volatility (0.00).
ASFX vs TUTH Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, TUTH has a market cap of 8.5M. Regarding current trading prices, ASFX is priced at $0.00, while TUTH trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas TUTH's P/E ratio is -3.59. In terms of profitability, ASFX's ROE is +0.00%, compared to TUTH's ROE of +0.31%. Regarding short-term risk, ASFX is less volatile compared to TUTH. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs IMTH Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, IMTH has a market cap of 6.5M. Regarding current trading prices, ASFX is priced at $0.00, while IMTH trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas IMTH's P/E ratio is -0.33. In terms of profitability, ASFX's ROE is +0.00%, compared to IMTH's ROE of +2.29%. Regarding short-term risk, ASFX is less volatile compared to IMTH. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs RSCF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, RSCF has a market cap of 5.8M. Regarding current trading prices, ASFX is priced at $0.00, while RSCF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas RSCF's P/E ratio is -6.73. In terms of profitability, ASFX's ROE is +0.00%, compared to RSCF's ROE of +0.08%. Regarding short-term risk, ASFX is less volatile compared to RSCF. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs BLMHF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, BLMHF has a market cap of 5.2M. Regarding current trading prices, ASFX is priced at $0.00, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, ASFX's ROE is +0.00%, compared to BLMHF's ROE of N/A. Regarding short-term risk, ASFX and BLMHF have similar daily volatility (0.00).
ASFX vs PXMVF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, PXMVF has a market cap of 4.6M. Regarding current trading prices, ASFX is priced at $0.00, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, ASFX's ROE is +0.00%, compared to PXMVF's ROE of N/A. Regarding short-term risk, ASFX is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs CBSC Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, CBSC has a market cap of 4.2M. Regarding current trading prices, ASFX is priced at $0.00, while CBSC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas CBSC's P/E ratio is -3.70. In terms of profitability, ASFX's ROE is +0.00%, compared to CBSC's ROE of +1.21%. Regarding short-term risk, ASFX is less volatile compared to CBSC. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs ECIA Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, ECIA has a market cap of 4M. Regarding current trading prices, ASFX is priced at $0.00, while ECIA trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas ECIA's P/E ratio is -17.00. In terms of profitability, ASFX's ROE is +0.00%, compared to ECIA's ROE of -0.33%. Regarding short-term risk, ASFX and ECIA have similar daily volatility (0.00).
ASFX vs NSTGQ Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, NSTGQ has a market cap of 3.3M. Regarding current trading prices, ASFX is priced at $0.00, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to NSTGQ's ROE of N/A. Regarding short-term risk, ASFX is less volatile compared to NSTGQ. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs PDMI Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, PDMI has a market cap of 324.9K. Regarding current trading prices, ASFX is priced at $0.00, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas PDMI's P/E ratio is -0.01. In terms of profitability, ASFX's ROE is +0.00%, compared to PDMI's ROE of +0.19%. Regarding short-term risk, ASFX and PDMI have similar daily volatility (0.00).
ASFX vs REMI Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, REMI has a market cap of 200K. Regarding current trading prices, ASFX is priced at $0.00, while REMI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas REMI's P/E ratio is -1.00. In terms of profitability, ASFX's ROE is +0.00%, compared to REMI's ROE of -0.08%. Regarding short-term risk, ASFX and REMI have similar daily volatility (0.00).
ASFX vs CEOS Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, CEOS has a market cap of 154.4K. Regarding current trading prices, ASFX is priced at $0.00, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas CEOS's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to CEOS's ROE of +1.18%. Regarding short-term risk, ASFX is less volatile compared to CEOS. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs QTXB Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, QTXB has a market cap of 118K. Regarding current trading prices, ASFX is priced at $0.00, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas QTXB's P/E ratio is -0.05. In terms of profitability, ASFX's ROE is +0.00%, compared to QTXB's ROE of +0.00%. Regarding short-term risk, ASFX is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs SDCCQ Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SDCCQ has a market cap of 80.5K. Regarding current trading prices, ASFX is priced at $0.00, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, ASFX and SDCCQ have similar daily volatility (0.00).
ASFX vs SVSO Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SVSO has a market cap of 63.8K. Regarding current trading prices, ASFX is priced at $0.00, while SVSO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SVSO's P/E ratio is -0.17. In terms of profitability, ASFX's ROE is +0.00%, compared to SVSO's ROE of +0.17%. Regarding short-term risk, ASFX and SVSO have similar daily volatility (0.00).
ASFX vs LANZ Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, LANZ has a market cap of 27.7K. Regarding current trading prices, ASFX is priced at $0.00, while LANZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas LANZ's P/E ratio is 1.00. In terms of profitability, ASFX's ROE is +0.00%, compared to LANZ's ROE of +0.01%. Regarding short-term risk, ASFX and LANZ have similar daily volatility (0.00).
ASFX vs GMVDF Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, GMVDF has a market cap of 26K. Regarding current trading prices, ASFX is priced at $0.00, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas GMVDF's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to GMVDF's ROE of +3.68%. Regarding short-term risk, ASFX and GMVDF have similar daily volatility (0.00).
ASFX vs VSMD Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, VSMD has a market cap of 22.4K. Regarding current trading prices, ASFX is priced at $0.00, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas VSMD's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to VSMD's ROE of +3.15%. Regarding short-term risk, ASFX and VSMD have similar daily volatility (0.00).
ASFX vs MDIT Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, MDIT has a market cap of 17.2K. Regarding current trading prices, ASFX is priced at $0.00, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas MDIT's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to MDIT's ROE of -0.99%. Regarding short-term risk, ASFX and MDIT have similar daily volatility (0.00).
ASFX vs INND Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, INND has a market cap of 15.2K. Regarding current trading prices, ASFX is priced at $0.00, while INND trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas INND's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to INND's ROE of +0.32%. Regarding short-term risk, ASFX is less volatile compared to INND. This indicates potentially lower risk in terms of short-term price fluctuations for ASFX.
ASFX vs LFPI Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, LFPI has a market cap of 10.2K. Regarding current trading prices, ASFX is priced at $0.00, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas LFPI's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to LFPI's ROE of -4.85%. Regarding short-term risk, ASFX and LFPI have similar daily volatility (0.00).
ASFX vs SECI Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SECI has a market cap of 9.2K. Regarding current trading prices, ASFX is priced at $0.00, while SECI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SECI's P/E ratio is -0.18. In terms of profitability, ASFX's ROE is +0.00%, compared to SECI's ROE of -0.00%. Regarding short-term risk, ASFX and SECI have similar daily volatility (0.00).
ASFX vs DGEN Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, DGEN has a market cap of 3.9K. Regarding current trading prices, ASFX is priced at $0.00, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas DGEN's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to DGEN's ROE of +0.05%. Regarding short-term risk, ASFX and DGEN have similar daily volatility (0.00).
ASFX vs WHSI Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, WHSI has a market cap of 1.8K. Regarding current trading prices, ASFX is priced at $0.00, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas WHSI's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to WHSI's ROE of +0.84%. Regarding short-term risk, ASFX and WHSI have similar daily volatility (0.00).
ASFX vs BLFE Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, BLFE has a market cap of 1.6K. Regarding current trading prices, ASFX is priced at $0.00, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas BLFE's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to BLFE's ROE of +0.00%. Regarding short-term risk, ASFX and BLFE have similar daily volatility (0.00).
ASFX vs SEYE Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, SEYE has a market cap of 1.2K. Regarding current trading prices, ASFX is priced at $0.00, while SEYE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas SEYE's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to SEYE's ROE of N/A. Regarding short-term risk, ASFX and SEYE have similar daily volatility (0.00).
ASFX vs BGMD Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, BGMD has a market cap of 1.1K. Regarding current trading prices, ASFX is priced at $0.00, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas BGMD's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to BGMD's ROE of +0.00%. Regarding short-term risk, ASFX and BGMD have similar daily volatility (0.00).
ASFX vs ADLI Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, ADLI has a market cap of 1K. Regarding current trading prices, ASFX is priced at $0.00, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas ADLI's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to ADLI's ROE of +1.36%. Regarding short-term risk, ASFX and ADLI have similar daily volatility (0.00).
ASFX vs MICRD Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, MICRD has a market cap of 317. Regarding current trading prices, ASFX is priced at $0.00, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas MICRD's P/E ratio is -0.00. In terms of profitability, ASFX's ROE is +0.00%, compared to MICRD's ROE of -0.25%. Regarding short-term risk, ASFX and MICRD have similar daily volatility (0.00).
ASFX vs HRAL Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, HRAL has a market cap of 297. Regarding current trading prices, ASFX is priced at $0.00, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas HRAL's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to HRAL's ROE of +0.13%. Regarding short-term risk, ASFX and HRAL have similar daily volatility (0.00).
ASFX vs RGBOQ Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, RGBOQ has a market cap of 97. Regarding current trading prices, ASFX is priced at $0.00, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, ASFX's ROE is +0.00%, compared to RGBOQ's ROE of N/A. Regarding short-term risk, ASFX and RGBOQ have similar daily volatility (0.00).
ASFX vs VTEQ Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, VTEQ has a market cap of 1. Regarding current trading prices, ASFX is priced at $0.00, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, ASFX's ROE is +0.00%, compared to VTEQ's ROE of N/A. Regarding short-term risk, ASFX and VTEQ have similar daily volatility (0.00).
ASFX vs OCPNY Comparison
ASFX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASFX stands at 17.5K. In comparison, OCPNY has a market cap of 0. Regarding current trading prices, ASFX is priced at $0.00, while OCPNY trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASFX currently has a P/E ratio of N/A, whereas OCPNY's P/E ratio is N/A. In terms of profitability, ASFX's ROE is +0.00%, compared to OCPNY's ROE of +0.26%. Regarding short-term risk, ASFX and OCPNY have similar daily volatility (0.00).